Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adaptive Deep Brain Stimulation Targeting the Interposed Nucleus to Treat Spinocerebellar Ataxia

NCT07325487 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.

NCT NCT07325487
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07325487 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adaptive Deep Brain Stimulation Targeting the Interposed Nucleus to Treat Spinocerebellar Ataxia
Lead sponsor
University of Florida
Phase
Not applicable
Overall status
Recruiting
Start date
June 2, 2026
Completion date
June 30, 2031
Enrollment
5 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spinocerebellar ataxia (sca), spinocerebellar ataxia type 6